Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
Clinical trial NCT02253459 · COMPLETED
Trial details
- NCT number
- NCT02253459
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-09-01
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.